Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease
fluticasone furoate/vilanterol
HZC113782
NCT01313676
Pulmonary Disease, Chronic Obstructive
Phase 3
 
Please note that there is a Publication Steering Committee for this study.
June 2016

Powered by ideaPoint, Inc.